stockrowAnaptysBio, Inc. (ANAB) vs Ocular Therapeutix, Inc. (OCUL)
- AnaptysBio, Inc. ANAB 46.43 +1.86%
- Ocular Therapeutix, Inc. OCUL 6.62 +2.95%
AnaptysBio, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.4B and $1.4B). AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against −8.14%. AnaptysBio, Inc. has the higher net margin (−11.5% vs −579.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, AnaptysBio, Inc. leads on 14 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | ANAB | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.11% | 68.51% |
| Operating margin | 17.56% | (603.04%) | 0.00% |
| Net margin | (11.53%) | (579.10%) | 0.00% |
| Free cash flow margin | 1.90% | (490.07%) | 0.00% |
| Return on equity | (114.55%) | (72.99%) | (51.96%) |
| Return on assets | (7.13%) | (53.70%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack